Related Experiment Video

Updated: Mar 15, 2026

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
10:42

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models

Published on: October 22, 2012

16.8K

Role of NADPH Oxidase in Metabolic Disease-Related Renal Injury: An Update

Cheng Wan1, Hua Su1, Chun Zhang1

  • 1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.

Oxidative Medicine and Cellular Longevity
|September 7, 2016
PubMed

Insights

Metabolic syndrome increases chronic kidney disease risk. NADPH oxidase-induced oxidative stress in kidney cells drives this injury, offering potential therapeutic targets.

Area of Science:

  • Nephrology
  • Metabolic Diseases
  • Oxidative Stress

Background:

  • Metabolic syndrome is a known risk factor for chronic kidney disease (CKD).
  • The precise mechanisms linking metabolic dysfunction to kidney damage are not fully understood.
  • Oxidative stress is implicated in the progression of kidney diseases.

Purpose of the Study:

  • To review the role of NADPH oxidase in metabolic syndrome-related kidney injury.
  • To elucidate the contribution of oxidative stress to glomerular diseases in metabolic syndrome.
  • To identify potential therapeutic avenues targeting NADPH oxidase.

Main Methods:

  • Literature review focusing on NADPH oxidase and kidney disease.
  • Analysis of studies investigating oxidative stress in podocytes, endothelial cells, and mesangial cells.
  • Synthesis of evidence linking metabolic factors to reactive oxygen species (ROS) production.

Main Results:

  • NADPH oxidase is a primary source of intrarenal oxidative stress.
  • Metabolic factors upregulate NADPH oxidase activity.
  • Overproduction of ROS by NADPH oxidase contributes to glomerular cell damage and disease initiation/progression.

Conclusions:

  • NADPH oxidase-driven oxidative stress is a key player in metabolic syndrome-related renal injury.
  • Understanding this pathway is crucial for developing targeted therapies for CKD in metabolic syndrome patients.

More Related Videos

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

1.3K
ROS Live Cell Imaging During Neuronal Development09:25

ROS Live Cell Imaging During Neuronal Development

Published on: February 9, 2021

4.9K

Related Concept Videos

Redox Reactions01:27

Redox Reactions

Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
1.3K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
78
Role of Reduced Coenzymes NADH and FADH₂01:29

Role of Reduced Coenzymes NADH and FADH₂

The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
18.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
941
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
5.5K